Search results for "actors"

showing 10 items of 11323 documents

Renal protection by antihypertensive drugs

1998

During the last few years there has been a renewed interest in blood-pressure (BP)-induced kidney damage, owing to a progressive increase in the incidence and prevalence of hypertension and vascular diseases as a cause of end-stage renal disease (ESRD). The need to prevent ESRD demands continued efforts so as to identify early those people with hypertension who are at risk and to provide them with effective antihypertensive therapy. This review analyses what is needed in terms of surrogate endpoints for monitoring kidney damage and what is known about the impact of antihypertensive treatments in reducing the BP burden on the kidney in non-diabetic subjects. Although glomerular filtration ra…

medicine.medical_specialtyPhysiologymedicine.drug_classRenal functionBlood PressureKidneyurologic and male genital diseasesEssential hypertensionNephropathyRisk FactorsInternal medicineInternal MedicinemedicineAlbuminuriaHumansAntihypertensive drugAntihypertensive AgentsKidneyProteinuriabusiness.industrySurrogate endpointmedicine.diseasefemale genital diseases and pregnancy complicationsEndocrinologymedicine.anatomical_structureHypertensionCardiologyKidney Failure ChronicMicroalbuminuriamedicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of Hypertension
researchProduct

Thrombosis

2014

Background— Thrombosis is the common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused 1 in 4 deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. Objective— To review the literature on the global burden of disease caused by VTE. Approach and Results— We performed a systematic review of the literature on the global disease burden because of VTE in low-, middle-, and high-income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded…

medicine.medical_specialtyPopulation ageingPopulationMyocardial IschemiaDisease030204 cardiovascular system & hematologyGlobal HealthCohort Studies03 medical and health sciencesLife Expectancy0302 clinical medicineCost of IllnessCause of DeathEnvironmental healthGlobal healthPrevalenceHumansMedicinecardiovascular diseases030212 general & internal medicineIntensive care medicineeducationStrokeDisease burdenCause of deathVenous Thrombosiseducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)Racial GroupsAge FactorsThrombosisVenous ThromboembolismHematologymedicine.diseaseThrombosis3. Good healthStrokePneumoniaVenous thrombosisSocial ClassQuality-Adjusted Life YearsMedical emergencyPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessArteriosclerosis, Thrombosis, and Vascular Biology
researchProduct

Prevention of venous thromboembolic events occurring in myeloma patients treated with second-generation novel agents

2021

Thrombosis and neoplasms are strictly linked, and the diagnosis of a malignancy is a relevant risk factor for venous thromboembolism (VTE). In particular, between gammopathies, the VTE risk is known to be increased in both monoclonal gammopathy of uncertain significance and in multiple myeloma, with a 3- and 9-fold increase respectively, when compared to the general population. The risk appears to be further increased in patients treated with immunomodulating drugs, such as thalidomide, especially when in combination with dexamethasone or conventional cytotoxic chemotherapies, and lenalidomide. In 2008 the International Myeloma Working Group put out thrombosis prophylaxis recommendations fo…

medicine.medical_specialtyPopulationAntineoplastic Agents030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesAntineoplastic Agents Immunological0302 clinical medicineFibrinolytic AgentsRisk FactorsInternal medicinemedicineHumansImmunologic FactorsRisk factoreducationMultiple myelomaLenalidomideeducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryWarfarinAnticoagulantsVenous ThromboembolismGeneral MedicineEvidence-based medicinemedicine.diseaseThrombosisPrevention and controlThalidomideTreatment OutcomeMultiple MyelomabusinessProteasome Inhibitorsmedicine.drugPanminerva Medica
researchProduct

Evaluation of C-Reactive Protein in Primary and Secondary Prevention

2007

Inflammation is pivotal in atherosclerosis, and C-reactive protein (CRP) is an inflammatory marker that predicts cardiovascular events. Several population-based studies have demonstrated that baseline CRP levels predict future cardiovascular events. CRP testing may thus have a major adjunctive role in the global assessment of cardiovascular risk. Recently, the National Cholesterol Education Program, through the Adult Treatment Panel III guidelines, identified CRP and another marker of inflammation, the fibrinogen, as “emerging risk factors,” suggesting that their measurement may improve the estimations of absolute risk obtained using the traditional cardiovascular risk factors. In terms of…

medicine.medical_specialtyPopulationDiseaseFibrinogenGeneral Biochemistry Genetics and Molecular BiologyRisk FactorsInternal medicineHumansMass ScreeningMedicineeducationNational Cholesterol Education Programeducation.field_of_studyFramingham Risk Scorebiologybusiness.industryC-reactive proteinAbsolute risk reductionGeneral MedicineAtherosclerosismedicine.diseaseC-Reactive ProteinPhysical therapybiology.proteinMetabolic syndromebusinessmedicine.drugJournal of Investigative Medicine
researchProduct

A systematic review of neuropsychiatric symptoms in mild cognitive impairment.

2009

Mild cognitive impairment (MCI) is a clinical concept proposed as an intermediate state between normal aging and dementia. This condition has multiple heterogeneous sources, including clinical presentation, etiology, and prognosis. Recently, the prevalence and associated features of neuropsychiatric symptoms (NPS) in MCI have been described. We systematically searched the PubMed database (last accessed on August 31, 2008) for articles on NPS in MCI. Included articles used strict selection criteria, and outcome variables were extracted in duplicate; of the 27 articles included, 14 (52%) used prospective cohorts. The global prevalence of NPS in MCI ranged from 35% to 85%. The most common beha…

medicine.medical_specialtyPopulationDiseaseNeuropsychological TestsIrritabilitybehavioral disciplines and activitiesAlzheimer DiseaseRisk FactorsInternal medicinemental disordersmedicineDementiaAlzheimer’s disease behavior dementia depression incidence mild cognitive impairment neuropsychiatric symptoms predictors prevalence risk factorsHumansProspective cohort studyeducationDepression (differential diagnoses)education.field_of_studyClinical Trials as TopicGeneral NeuroscienceMental DisordersGeneral Medicinemedicine.diseasePsychiatry and Mental healthClinical PsychologyEtiologyAnxietySettore MED/26 - NeurologiaGeriatrics and Gerontologymedicine.symptomPsychologyCognition DisordersClinical psychologyJournal of Alzheimer's disease : JAD
researchProduct

The controversial relationship between exercise and atrial fibrillation: clinical studies and pathophysiological mechanisms

2015

Atrial fibrillation is the most common clinically significant arrhythmia observed both in the general population and in competitive athletes. The most important risk factors are all preventable by regular physical activity. However, although the benefits of moderate physical activity in controlling cardiovascular risk factors and decreasing the risk of atrial fibrillation have been extensively proved, concerns have arisen about the potential negative effects of vigorous exercise, particularly in endurance athletes. Furthermore, in a subset of patients with atrial fibrillation younger than 60 years, routine evaluation does not reveal any cardiovascular disease or any other known causal facto…

medicine.medical_specialtyPopulationDiseaseatrial functionRisk FactorsFibrosisInternal medicinemedicineHumansatrial fibrillationcardiovascular diseasesVagal toneExercise physiologyeducationarrhythmias athlete’s heart atrial fibrillation atrial remodeling sports activityeducation.field_of_studybiologyexerciseAthletesbusiness.industryatrial fibrillation exercise atrial functionAtrial fibrillationAtrial RemodelingGeneral Medicinemedicine.diseasebiology.organism_classificationSettore MED/11 - Malattie Dell'Apparato CardiovascolareExercise TherapyReview articlecardiovascular systemCardiologyCardiology and Cardiovascular MedicinebusinessSports
researchProduct

Alcohol-based mouthwash as a risk factor of oral cancer: A systematic review

2019

Background Oral and pharynx cancer represent a serious global problem, reaching an incidence of half a million cases annually. The role of tobacco and alcohol have been studied and proven to be one of its risk factors. We also know that mouthwashes contain a variable percentage of alcohol, so there is a reasonable concern about their role in carcinogenesis. Material and Methods To answer the PICOS (Population; Intervention; Comparison; Outcomes; Study) question: "Do patients (Population) who use alcohol-based mouthwashes (Intervention) compared to those who do not use them (Comparison) have higher acetaldehyde levels in saliva or higher risk of oral cancer development? (Outcomes)" Meta-anal…

medicine.medical_specialtyPopulationMouthwashesReviewCochrane Library03 medical and health sciences0302 clinical medicinestomatognathic systemOral hygieneRisk FactorsInternal medicineHumansMedicineProspective StudiesRisk factoreducationProspective cohort studyGeneral DentistryRetrospective StudiesMouth neoplasmeducation.field_of_studyOral Medicine and Pathologybusiness.industryOral cancerRetrospective cohort study030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Càncer de bocaHigiene bucalSystematic reviewOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASMouth NeoplasmsSurgerybusinessCohort study
researchProduct

Risk Weighing in Twin Pregnancy

2010

Multiple pregnancies are more often associated with complications than singleton pregnancies. In our retrospective study of 613 twin pregnancies the most important risk factors in twin pregnancies were premature labour before the 37th week of gestation and the premature rupture of the membrane. The increase of perinatal mortality and morbidity for twins might be primary the result of premature delivery.

medicine.medical_specialtyPremature labourObstetricsPerinatal mortalitybusiness.industrySingletonPregnancy OutcomeTwinsObstetrics and GynecologyRetrospective cohort studyObstetric Labor PrematurePregnancyRisk FactorsmedicineHumansGestationFemalePregnancy MultiplebusinessTwin PregnancyRetrospective StudiesAsia-Oceania Journal of Obstetrics and Gynaecology
researchProduct

Review: Epidemiology of Helicobacter pylori infection

2019

This review summarizes recent publications on the epidemiology of Helicobacter pylori. Two major systemic analyses, from Malaysia and Ethiopia, were published. The Brazilian Consensus Conference has stated that H pylori infection is an infectious disease with an indication for antimicrobial therapy. A continuous decrease in H pylori prevalence was reported from many regions worldwide, including Korea, China, Iran, and Austria. A cross-sectional H pylori prevalence study conducted in the United Arab Emirates found 41% prevalence in a group of healthy children and adults. Several studies from Asia addressed H pylori prevalence in adults undergoing regular checkup. The largest of such studies,…

medicine.medical_specialtyPrevalenceDiseaseGlobal HealthHelicobacter Infections03 medical and health sciences0302 clinical medicineRisk FactorsEnvironmental healthEpidemiologyPrevalencemedicineHumansSeroprevalenceStomach cancerHelicobacter pyloribiologybusiness.industryGastroenterologyWaterborne diseasesGeneral MedicineHelicobacter pyloribiology.organism_classificationmedicine.diseaseInfectious DiseasesInfectious disease (medical specialty)030220 oncology & carcinogenesis030211 gastroenterology & hepatologybusinessHelicobacter
researchProduct

Predicting Venous Thromboembolism in Primary Care

2020

medicine.medical_specialtyPrimary Health Carebusiness.industryPrimary health careMEDLINEAnticoagulantsVenous ThromboembolismHematologyPrimary careRisk FactorsmedicineHumansIntensive care medicinebusinessVenous thromboembolismThrombosis and Haemostasis
researchProduct